Menu
Search
|

Menu

Close
X

Meridian Bioscience Inc VIVO.OQ (NASDAQ Stock Exchange Global Select Market)

11.52 USD
-- (--)
As of Jul 17
Previous Close 11.52
Open --
Volume --
3m Avg Volume 114,557
Today’s High --
Today’s Low --
52 Week High 19.82
52 Week Low 10.77
Shares Outstanding (mil) 42.63
Market Capitalization (mil) 491.08
Forward P/E 18.62
Dividend (Yield %) 0.12 ( 4.34 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.50 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY19
102
FY18
214
FY17
201
FY16
196
EPS (USD)
FY19
0.354
FY18
0.516
FY17
0.506
FY16
0.760
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
18.62
34.16
Price to Sales (TTM)
vs sector
2.38
8.16
Price to Book (MRQ)
vs sector
2.70
4.38
Price to Cash Flow (TTM)
vs sector
14.22
24.12
Total Debt to Equity (MRQ)
vs sector
26.40
18.17
LT Debt to Equity (MRQ)
vs sector
23.09
13.01
Return on Investment (TTM)
vs sector
11.56
12.64
Return on Equity (TTM)
vs sector
14.90
17.19

EXECUTIVE LEADERSHIP

David Phillips
Chairman of the Board, Director, Since 2018
Salary: --
Bonus: --
John Kenny
Chief Executive Officer, Director, Since 2017
Salary: $542,408.00
Bonus: --
Bryan Baldasare
Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller, Treasurer, Since 2019
Salary: --
Bonus: --
Lawrence Baldini
Executive Vice President and President - Global Operations, Since 2016
Salary: $350,804.00
Bonus: --
James Anderson
Independent Director, Since 2009
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

3471 River Hills Dr
CINCINNATI   OH   45244

Phone: +1513.2713700

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

SPONSORED STORIES